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ABSTRACT 
 
Objectives: To evaluate the relation between ventilation tube insertion, otitis media with 
effusion duration and otologic outcomes in unilateral cleft lip and/or cleft palate children 
from infancy to teenage age. 
 
Design and Population: Retrospective longitudinal charts review of patients from the 
multidisciplinary cleft team of the University Hospital of Lausanne over a 30-year period. 
146 charts from consecutive patients with non-syndromic unilateral cleft lip and/or cleft 
palate who were born between January 1986 and January 2003 were included. 
 
Results: 
The earlier in life a cleft child experience his first otitis media with effusion (OME), the 
worse his long-term hearing will be. Along with the age of onset of OME, we disclosed an 
influence of the duration of OME without ventilation tube (VT) insertion on short and long-
term hearing outcomes. Different patterns were observed between cleft palate (CP) and cleft 
lip palate children (CLP), with a higher incidence of otitis media with effusion for the CLP 
group than the CP group. Direct positive relationship between VT insertion and hearing were 
disclosed and evaluation of long-term complications did not reveal significant relation with 
VT insertion.  
Of note, OME in CLP children led to a higher rate (but not statistically significant) of chronic 
ear complications than in the CP group, that may indicate more persistent OME or different 
adverse effect on the middle ear mucosa between CP and CLP children. 
 Conclusions:  
Individualized counseling should take into account different factors such as the type of cleft, 
the age of onset of OME and duration of OME, keeping in mind the adverse effect of 
persistent middle ear fluid. In the present report, results prone an early ventilation tube 
insertion to prevent short and long-term injury to the middle ear homeostasis, hearing loss 
and related issues.   
 
Keywords: unilateral cleft lip and palate, hearing loss, complications, long-term outcomes 
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INTRODUCTION 
 
 
Orofacial clefting is a congenital anomaly that encompasses a wide range of malformation, 
including unilateral or bilateral cleft lip (CL), unilateral of bilateral cleft lip and palate (CLP) 
and cleft palate (CP), isolated or associated to a syndrome. In Switzerland, the birth 
prevalence of CL with or without CP is between 0.83 to 0.96 and for isolated cleft palate 
from 0.59 to 0.69 per 1000 live-born babies.1 The incidence of unilateral cleft is nine times 
higher than bilateral clefts and unilateral clefts are more frequently on the left than on the 
right side. Isolated CP more frequently concerns females whereas CLP predominantly affects 
males. 
Otitis media with effusion (OME) is a common pathology of childhood defined as the 
presence of fluid (build-up of mucus or liquid) in the middle ear without signs or symptoms 
of acute ear infection whereas its persistence over a 3 month-period defines a chronic OME.2 
In the general population, 50% of children are reported to experience at least one OME in the 
first year of life, increasing to 60% by the age of 2.3 However children with CP and CLP 
experience a greater number of OME than the general population4 and chronic secretory otitis 
media is suggested to develop in almost all infants with cleft palate within the first month of 
life.5 Of the different predisposing factors, the Eustachian tube dysfunction plays a major role 
in the pathogenesis of the OME in infants with CP and CLP.6 The structure of the Eustachian 
tube in cleft children presents differences as compared with general specimens7 and the lack 
of insertion of the tensor and levator palate muscles into the midline palate prevents normal 
opening of the nasopharyngeal end of the Eustachian tube, efficient pressure regulation and 
secretion clearance.8,9 Cleft patients are at higher risk of middle ear effusion in comparison 
with general population and the prevalence of OME remains high even in teenage age with 
13% to 49% of adolescents with CLP reported with OME.10 Based on these observations, 
several authors advocate early ventilation tube (VT) insertion during the primary palatal 
repair to limit the impact of hearing loss on speech and language development and to prevent 
long-lasting effects of chronic OME.11,12 A VT allows the fluid to drain and decreases 
secretion from the mucosa by providing aeration and equalization of pressure to the middle 
ear cavity.13 Albeit a positive effect on short term hearing, VT insertion is for some authors 
not devoid of adverse effects: 14  a 2005 Cochrane review of randomized controlled trials15 
comparing effectiveness of short-term ventilation tube insertion with myringotomy or 
nonsurgical treatment in non-cleft children with middle ear effusion, concluded that the effect 
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of short-term ventilation tube on hearing was small and diminished over the first year. Such 
findings led some groups to focus on the use of possible hearing aids to avoid problems 
associated with repeated VT insertion.16   
Close follow-up is required from birth until adulthood as affected children present higher 
morbidity and mortality throughout life than the general population.17,18 Especially recurrent 
middle ear problems have to be carefully monitored during the critically period of speech and 
language acquisition, social behavior development and for years as complications and long-
lasting hearing loss can occur.14,19 Since 1986, we adopted a multidisciplinary team approach 
strategy, including pediatric surgery, nursing, maxillofacial surgery, otolaryngology, 
audiology, speech therapy, psychology, genetics, orthodontics, and thus provided children 
with a centralized care strategy. However, despite growing interest towards long-lasting 
adverse effects in CLP and CP children, evidence for the effective management of OME in 
these children is still incomplete and uncertainties among clinicians remain.20,21 
The aim of this study was to evaluate the potential benefits and harms of our care strategy 
(VT insertion or watchful waiting) at different ages from childhood until 15 years. The 15 
years ending time-point was chosen in reference to the end of normal school in Switzerland, a 
transition from teenage to adulthood.  
We examined the relation between VT insertion, OME duration and otologic outcomes in our 
cohort of non-syndromic CP and CLP children longitudinally followed over time in the same 
tertiary care center to assess a better picture of prevalence and factor influences at 2, 4, 6, 8 
10 and 15 years of age.  
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SUBJECTS AND METHODS 
 
 
Design  
This study involved a detailed longitudinal retrospective chart review from a consecutive 
series of children over a 30-year period. Data pertaining to the clinical characteristics of the 
children were collected for all children from the multidisciplinary cleft palate team at the 
Lausanne University Hospital. This study was approved by the ethic comity of Canton de 
Vaud (CER_VD 2016-00862).  
 
Participants and setting  
This study was undertaken at a single institution, the Lausanne University Hospital, 
Switzerland, a tertiary care medical facility where comprehensive orofacial cleft services 
including assessment, speech therapy, surgery, audiologic and early rehabilitation 
intervention have been in place since 1986. As part of standard care, children with orofacial 
cleft undergo a comprehensive interdisciplinary team assessment with professionals 
representing pediatric surgery, maxilla-facial surgery, audiology, speech-language 
intervention, otolaryngology, and psychology as well as other developmental and medical 
services (e.g. developmental pediatrician) if required. 
Data were collected from a consecutive series of children treated within the same centralizing 
service over a 30-year period. Inclusion criteria comprised the following: 
- Children born with unilateral cleft lip and palate (CLP) and children with only cleft palate 
(CP) without associated syndrome, chromosomal abnormality or sequence  
- Children born between January 1986 and January 2002 and followed from birth to 15 years 
of age by the multidisciplinary cleft palate team. 
- Data available from birth to 15 years of age during multidisciplinary consultations and 
clinical ENT visits. 
Children with cleft lips only, children who had undergone cleft repair at an outside hospital or 
had an intact secondary palate, children lost from the follow up, children with co-existing 
syndrome or children with sensorineural or mixed hearing loss were excluded from the study. 
 
Surgical, clinical treatment and outcome measures:  
Surgical intervention strategy was performed according to the von Langenbeck  procedure.22  
Timing of primary surgical repair did not vary significantly across population. Children with 
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a CLP underwent palatal surgery at a mean age of 4.8 months (SD = 3.1) and CP children 
underwent palatoplasty around 6.4 months of life (SD = 3.3; mean = 6.3 months for the group 
with less than half of the roof involved and 6.7 months for the other subgroup).  
Hearing assessments were performed at the Audiology clinic and included otomicroscopy, 
tympanometry and pure-tone audiometry by the same experienced pediatric otolaryngologist. 
Otomicroscopy findings were classified as normal or abnormal (OME, tympanic retraction, 
tympanic perforation, cholesteatoma, tympanosclerosis) and completed with tympanometry 
evaluation. Middle ear effusion was classified as untreated if no short-term ventilation tube 
was present within the 5-days period prior or after its diagnosis. Middle ear impedance was 
assessed using a Grason-Stadler GSI28A tympanometer and hearing thresholds were 
ascertained from 500 to 4000 Hz for each ear using pure-tones under headphones with an 
GrasonStadler GSI-16 earphone audiometer (Grason-Stadler, Littleton, MA, USA). For 
young children, the experienced audiologists chose the most appropriate testing between 
behavioral, visually reinforced, or conditioned-play audiometry to obtain ear and frequency 
specific thresholds. Hearing loss was defined as >20 dB and thresholds were classified as 
normal for responses at intensities ≤ 20 dB HL, mild hearing loss was diagnosed for 
thresholds between 21 to 40 dB HL whereas moderate hearing loss was considered for 
thresholds between 41 and 60 dB HL. Tympanostomy tubes were placed in case of 
persistence of otitis media with effusion (i.e. at least 3 months) and conductive hearing loss 
on sequential evaluations (>5 dB conductive loss with >20 dB pure tone average). Details 
related to the presence or absence of middle ear effusion, the number of VT, including age at 
insertion and complications, were computed at each visit. 
Data analysis  
The data are presented primarily descriptively using means, medians, or proportions as 
appropriate. Statistical analyses were conducted using Anaconda 2.7, a free distribution of the 
Python programming language (Python Software Foundation). Python Language Reference, 
version 2.7.), the python module Rpy2 (Available at https://pypi.python.org/pypi/rpy2) to 
link python with R 3.1.3 (R Core Team (2015). R: A language and environment for statistical 
computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-
project.org/). A multivariate analysis using logistic regression was performed, Odds ratio 
were calculated to assess the relationship between the following variables: duration of middle 
ear effusion without short-term ventilation tube insertion and hearing outcomes at 2, 4, 6, 8, 
10 and 15 years. Results were significant if the P-value was <0.05.   
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Statistics were reviewed by an experienced statistician listed as one of the co-authors.  
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RESULTS 
 
 
Sample description 
Two hundred eleven non-syndromic patients with either unilateral cleft lip and palate (CLP) 
or only cleft palate (CP) were identified from our database. Examination of their medical 
records showed that 65 of the 211 children were referred after their first year of life or were 
lost before 15 years of follow-up and 4 children presented with submucous cleft palate. Table 
I shows the demographics of the 146 children included in the present report.  
 
Age of onset of middle ear effusion 
The earlier onset of middle ear effusion was reported at 0.7 month in the CLP group, 0.2 in 
the CP group involving more than half of the roof and 2.7 months in the CP group involving 
less than half of the roof. No statistically significant difference was found between groups. 
Analyses did not reveal any significant relationship between age of onset of OME and 
hearing outcomes at 2, 4, 6 and 8 years of age. However, multivariate logistic regression 
between age of onset of OME and pathology revealed a trend (p = 0.056) between the 
pathology and the hearing at 15 years of age and a significant effect between age of onset 
OME and hearing at 15 years old. It revealed that the youngest a child experience his first 
OME the worse his hearing will be at 15 years of age (p = 0.043, OR = 0.750, CI = 0.557-
0.978). 
 
 Duration of OME without VT insertion: 
To assess the effect of lasting OME on hearing, we noted the OME episodes lasting more 
than 3 months and for which no VT insertion was performed during the following 7 days 
(Table IIa). Multiple logistic regressions focusing on the influence of OME duration without 
VT insertion, pathology (CP; CLP) at 2, 4, 6, 8, 10 and 15 years of age (Table IIb) revealed 
significant effect of OME without VT insertion at 8 years of age (p = 0.005, OR = 1.027) and 
a significant effect of the pathology at 10 years (p = 0.047, OR = 2.777). For 15 years of age, 
both the pathology (p = 0.018, OR = 5.346) and the OME duration without VT insertion (p = 
0.004, OR = 1.013) disclosed significant relationship. Children from the CLP group presented 
with a significant risk of hearing loss at 8 years (p = 0.016, OR = 1.032), at 15 years (p = 
0.014, OR = 1.020) and a trend at 10 and 15 years of age (p = 0.085). As the duration is 
disclosed in months, it means that a CLP child with OME will have a risk of abnormal 
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hearing increasing by 1.032 every month. Moreover, for a given child, suffering from a cleft 
lip palate increased drastically their risk of presenting an abnormal hearing at 15 years old 
with an Odds ratio of 5.33 times that of a child presenting with a cleft palate (p = 0.013, CI = 
1.584-24.423). 
 
Incidence of persistent OME and short-term ventilation tube insertion 
frequency: 
The measure of persistent otitis media with effusion frequency by cleft type during different 
periods from childhood to teenage (cumulative incidence or incidence proportion) is 
presented in table III. By the time CP and CLP children reached 4-year-old age group, the 
majority (62% and 75% respectively) had presented persistent middle ear effusion at some 
stage. Overall, cumulative incidence showed a great increase between 2 and 6 years of age 
for both group (CP and CLP) and stabilizes from 10 years of age. The incidence of persistent 
OME for the first 2 years after birth was quite similar between CP and CLP groups (with 
36% and 37% respectively). Of these patients, 10% of the CP and 14% of the CLP with OME 
had ventilation tube insertion before 2 years of age with these percentages increasing until 8-
years-old and stabilizing until 15 years of age. Of the 73 CP children (Table III), 41 (56%) 
did not benefit from ventilation tube insertion until 15 years of age. However, 20 out of those 
children had undergone one episode of middle ear effusion and 2 children experienced two 
episodes of otitis media with effusion. At 15 years of age, 40% (29/73) of the CPL and 22% 
(16/73) of the CP children had benefited from more than one VT insertion with a mean 
number of VT insertion of respectively 1.95 and  1.87 in the CPL and CP population (min = 
0, max = 5 for both groups). 
The cumulative incidence of OME doubled between 2 and 4 years of age, with an incidence 
of OME higher in the CLP group compared to the CP groups (Table III). 
 
Hearing and short-term ventilation tube insertion related to the age of the child: 
A peak incidence for hearing problems is seen in the 2-to 4 year olds who did not benefit 
from ventilation tube insertion (Table III, Figure 1&2). This hearing loss was classified as 
mild for 95% of the 2-year-old CLP children and 98% of the 2-year-old CP children. As 
shown in Figure 1a, until 6 years of age, CP children with VT exhibited better hearing 
outcomes than their pairs who did not benefit from VT insertion. Of the noticeable number of 
CP children who exhibited abnormal hearing at 8 years despite VT insertion (Fig.2, 95% 
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classified as mild and 5 % as moderate hearing loss), charts review revealed recurrent 
obstructed VT in the majority of these patients.  
Significant hearing improvements from VT insertion are disclosed for CLP children (Fig. 1b), 
with emphasize regarding the 0-6-year-olds (at 2 years of age: p = 0.06; at 4 years of age: p = 
0.019 and at 6 years of age p = 0.009). Although not statistically significant difference was 
observed after 6, a trend is still visible until 7 years of age. At 15 years old, 67% of CLP 
children had VT versus only 44% in the CP group, with a higher proportion of children 
suffering from abnormal hearing in the CLP group (mild hearing loss, Fig.2). Figure 1 depicts 
slightly different trends between CP and CLP children: influence of ventilation tube insertion 
is not blatant at 6 years of age and later (Fig. 1a) while it remains clear for the CLP children 
from birth to 7 years of age (Fig. 1b). Of note, CP children presented with a decreasing 
incidence of middle ear problems earlier in life than CLP children (Table III). 
To appraise the relative influence of VT insertion on hearing, we ran a logistic regression 
analysis focusing on the impact of undergoing at least one VT insertion on the hearing at 2, 4, 
6, 8, 10 and 15 years of age in the CP and CLP populations. When considering the CP 
children, the analysis did not disclose any statistically significant relation between VT and 
hearing. On the other hand, undergoing at least one VT insertion for a given CLP child who 
had experienced OME decreased his risk of abnormal hearing at the age of 4 (p = 0.036; OR 
= 0.167). Similar results were observed for the CLP population at 6 years of age (p = 0.010; 
OR = 0.158) but not at 8 years of age.  
 
Long-term middle ear complications: 
Otologic complications at 15 years of age are represented in Table IV. Tympanosclerosis is 
the most frequent complication for both groups whether the children had undergone or not 
VT insertions. Incidence of tympanosclerosis in the CLP group was 5 time higher in the 
subgroup of children that had undergone ventilation tube insertion, but without any statistical 
difference (t-test, p = 0.5). Of note, 7 (33%) of the 21 CLP children, who experienced VT 
insertion, had abnormal hearing at 15 years of age (mild hearing loss, Table IV). Noteworthy, 
the severity of the tympanosclerosis varied with the population considered. All children from 
the CLP group who had VT insertion and presented with hearing below normal at 15 years of 
age, suffered from severe (more than 80 % of the tympanic membrane involved) 
tympanosclerosis whereas all CP children with tympanosclerosis ( 39 children, 53%) had 
normal hearing at 15 years of age (Table IV).  
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Retracted tympanic membrane was the second most frequent chronic ear complication for 
both groups of children (Table IV). Regarding this condition, there was no statistical 
correlation between improvement in hearing outcomes at 15 years of age and forgoing of VT 
insertion procedure for the CLP nor the CP groups. Of the 9 CLP children who had 
complications without any VT insertion, all had a history of OME whereas 7 out of the 15 
CLP children with normal tympanic membrane TM and no VT insertion had a history of 
OME. Of note of the 12 CP children presenting with complications but without any VT 
insertion, 5 had history of OME and 17 of the 29 CP children with normal TM and no VT 
insertion had experienced OME (Table IV). 
DISCUSSION 
 
 
Despite numerous progress, long-term adverse outcomes of children born with cleft palate CP 
or cleft lip palate CLP remain a burden on the child’s health and social transition to 
adulthood. Herein, we took advantage of the multidisciplinary team approach provided from 
birth to adulthood in our tertiary care center to evaluate the influence of OME management 
on short and long-term for CP and CLP children. Such strategy enabled patients to benefit 
from the same standards of care for years and permitted detailed records of these children to 
be maintained. Retrospective data gathering is likely to be less accurate than data gathered 
prospectively. However, the population referred to the multidisciplinary consultation in our 
tertiary referral center came from a narrowed geographical area and all the patients included 
were followed by the multidisciplinary team and did not attend a consultation with an 
otorhinolaryngologist nor a pediatric surgeon at another hospital. Although a prospective 
study would be preferred, the population included is representative of the population referred 
to our consultation. It also has the advantage of a large enough longitudinal cohort providing 
valuable and useful information and accruing patients over a 30-year period to assess long-
term follow-up seemed most likely difficult. Moreover, when analyzing outcomes, the 
process of care has to be consistent so that reports can be useful by providing comparative 
data. 
In line with previous studies, the overall incidence of OME decreases with increasing age,23–
26
 and children with cleft lip and palate presented with a higher incidence of middle ear 
effusion than that for children with cleft palate only.26 The incidence variation of OME with 
age and cleft type (CP versus CLP) is in accordance with tympanometric studies that showed 
a higher frequency of type B tympanograms at the ages of one to three in the CLP children 
than in the CP group, decreasing at 7 to 12.23 These findings may suggest that the 
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characteristic conditions of each type of cleft (CP or CLP) will promote different patterns of 
middle ear disease development. Another consideration is the conflicting evidence previously 
reported regarding incidence of OME across ages for CLP children,12,24 in our report 
increasing cumulative incidence until 15 years of age with peak incidence between 2 and 4 
years of age. Indeed, incidence of OME among children without clefts varies with age and 
Eustachian tube morphology, exhibiting a peak between 2 and 6 years of age.27 Variation 
with age is directly related to the morphological changes of the Eustachian tube that lead to 
better tubal function. For CP children, decrease of OME was noted in previous studies 
following the age of 15 years23,24 whereas in the present report, CP children exhibited peak 
incidence between 2 and 4 years of age and increased cumulative incidence of OME from 2 
to 10 years of age with a stabilization of the cumulative incidence after 10 years of age. Such 
difference may be due to methodology differences: the previous studies focused on cross 
sectional analysis of different group ages whereas our report represents longitudinal data 
from the same population of children. OME is often associated with a conductive hearing 
loss. As previously noted by Flynn et al.26 in their longitudinal study on hearing loss and cleft 
type across different age groups, we observed a decrease in prevalence of hearing loss 
between 10 and 15 years in all type of cleft. Herein, we revealed hearing loss to vary with 
cleft type and age, with the CLP children more prone to abnormal hearing than in the CP 
group.  
Another relevant point was the VT insertion in relation to OME and the effect on hearing. 
Surprisingly, we observed a high incidence of hearing issue before 4 years of age for both CP 
and CLP and a low rate of VT insertion at 2 years. Indeed, the rates of VT insertion noted in 
our report at 2 years of age was lower than in the literature and overall our cohort of children 
underwent VT insertion later than in the reported literature.14,28 However, by promoting the 
restoration of a normal atmospheric pressure in middle ear, early VT insertion are suggested 
to play a role in the development of the mastoid air cell system in cleft children.29   
 
The positive influence of ventilation tube insertion on hearing outcomes is observed not only 
at 4, 6 and 8 years of age, but also on long-term hearing outcomes. Alongside with previous 
study emphasizing the use of VT, we interpret this finding as confirming and strengthening 
the previous suggestion that an aerated and well ventilated middle ear cavity on hearing and 
thereby provide children with optimal auditory stimulation on language development. 
Another key point was the age of VT insertion. Herein, we observed the negative effect of an 
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early age of OME onset and of a lasting OME without VT insertion on short and long-term 
hearing. This emphasizes as previously suggested the need of early VT insertion to prevent 
adverse outcomes.30,31 OME can disrupt the acoustic-mechanical properties of the middle ear 
system thereby causing a conductive hearing loss. 32,33 Impaired transmission of the acoustic 
signal may lead to impaired brainstem/cortical function,34,35 abnormal development of speech 
and language development (i.e. articulatory issues) with related psychological, emotional and 
social problems.36 It is also likely that the timing of deprivation plays a major role in the 
brain-based developmental impairments.37 Therefore, when an OME is suspected, clinician 
should obtain an audiometry to better assess OME influence on hearing loss.  
With regard to possible complications of VT insertion, several retrospective studies 
previously reported an increased rate of tympanic membrane scarring, tympanosclerosis, 
permanent TM perforations and otorrhea in cleft palate children secondary to VT insertion 
while conservative management had led to long term favorable audiometric outcomes.14,38,39 
However, the possible role of an active middle ear disease in the otologic complications was 
not evaluated neither mentioned. On the other hand, some studies suggested the use of 
hearing aids instead of VT insertion16,20 but the long-lasting adverse effects of chronic 
effusion on middle ear was not mentioned. Caution should be taken regarding middle ear 
persistent effusion that lead to biofilm formation40 and may damage both the middle ear and 
mastoid mucosa as well as the middle ear ossicles.41 With regard to the question of possible 
biofilm formation on indwelling device, a wide range of VT have been considered as highly 
efficient to prevent biofilm formation (e.g. ionized, coated fluoroplastic grommets,42 ion-
bombarded silicone43 or VT coated with albumin)44 and to decrease the rate of post-VT 
insertion otorrhea.45   In the present report, ear complications between VT and no VT 
insertion were no statistically different. We also noted that CLP children presented with a 
higher rate of OME and VT insertion than the children in the CP group. Such difference 
between the 2 groups may indicate more persistent OME or different adverse effect on the 
middle ear mucosa between CP and CLP children. These findings may support the CLP 
children to be a population at higher risk of sequelae from OME and hearing loss with long-
lasting adverse hearing effects than CP children. These findings underscore the clinical need 
for close follow-up to provide children with early VT insertion, preventing from middle ear 
mucosa damages. We also observed that tympanosclerosis was the most reported VT 
insertion-related complication and unrelated in both groups in line with literature data 
(incidence 11-37%).46 Eardrum retraction (with and without tympanosclerosis) was also 
observed but with an incidence lower than in the literature (26% for the CLP and 33% for the 
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CP group post VT insertion versus 11.5%-36.8%).16,36,47 However methodological variation 
prevents specific comparison between studies.46 As previously reported, tympanosclerosis 
had little influence on hearing.14,48 Of note, tympanosclerosis plaques can be due whether to a 
prior history of VT placement or to a chronic OME. Its impact on hearing depends on the size 
of the tympanosclerotic plaque, its site and the involvement of the ossicular chain, leading to 
different hearing outcomes ranging from normal hearing to varying degrees of hearing loss. 
In line with such consideration, no significant relationship between tympanosclerosis and VT 
insertion on long-term follow-up were observed in the CLP group, nor the CP group.  
 
 
 
Conclusion  
Findings from the current study are noteworthy in several respects. First, the current findings 
reveal marked dissimilarity in the pattern of middle ear problems with influence of age and 
cleft type on incidence of OME and related hearing. Second, they provide a strong evidence 
yet that OME care strategy in childhood influence the child’s development until transition 
from childhood to adulthood. The stronger predictor variables were the age of OME onset 
and the duration of OME without VT insertion. We will use the present findings to counsel 
patients and families and help in decision making that most children with cleft palate will 
experience middle ear effusion and thus related conductive hearing impairment during a 
critically period. VT insertion can be proposed as an effective option with relatively fewer 
and easier complications to handle.  
Future is the development of prospective data base collection to provide a best possible 
individualized strategy in children with cleft palate since birth, and a global coordinated 
multidisciplinary approach.   
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Tables  
 
    Boys (N, %) Girls (N, %) 
CLP (N=73) Left 26, 36% 23, 31.5% 
  Right 17, 23% 7, 9.5% 
CP (N=73) Split < half of the roof of the mouth 28, 38.5% 23, 31.5% 
 
Split > half of the roof of the mouth 11, 15% 11, 15% 
 
 
Table I. Cleft type versus gender. CLP = Children with unilateral cleft lip palate. CP = 
Children with cleft palate. 
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a. 
 
Age (year) 2 4 6 8 
Mean OME 
Duration 
without VT 
insertion (day) 
CP  90 178 288 423 
CLP 60.9 106 205 357 
 
 
b. 
  
At 8  
 
  At 10  
 
  At 15  
 
OR 95% CI P OR 95% CI P OR 95% CI P 
OME Duration  
without  
VT insertion  
(month) 
1.027 1.010-1.049 0.005 1.010 0.997-1.022 0.119 1.013 1.004-1.023 0.004 
Pathology 2.080 0.784-5.748 0.147 2.777 1.037-7.948 0.047 5.346 1.490-26.136 0.018 
 
Table II. Duration of OME without VT insertion. 
a. Mean duration in the CP and CLP cohort at different ages. 
b. Results of binary logistic regression analysis using the duration of middle ear effusion 
(MEE) without grommet insertion and the type of pathology (CP/CLP) as qualitative input 
variable and hearing at 8, 10 and 15 years of age as response variable.  
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Age (year) 
  
2 
Number 
(%) 
4 
Number 
(%) 
6 
Number 
(%) 
8 
Number 
(%) 
10 
Number 
(%) 
15 
Number 
(%) 
CP 
 
Children with at least 1 OME 
since birth.  26 36% 45 62% 50 68% 52 71% 53 73% 53 73% 
 with ≥ 1 grommet insertion 5 7% 19 26% 29 40% 32 44% 32 44% 32 44% 
CLP  
 
Children with at least 1 OME 
since birth.  27 37% 55 75% 60 82% 61 84% 61 84% 66 90% 
 with ≥ 1 grommet insertion 7 10% 27 36% 41 56% 44 60% 49 67% 49 67% 
 
Table III. Cumulative incidence of otitis media with effusion (OME) and grommet insertion 
in case of OME by cleft type and for different ages.  
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Grommet insertion 
At 15 years of age NO, n (%) YES, n (%) 
  CLP CP CLP CP 
Normal TM 15 29 10 5 
 
    
Chronic ear complications   
 
  
Tympanosclerosis 4 (16%) 7 (17%) 21 (42%) 8 (25%) 
TM perforation 1 (4%) 0 0 3 (9%) 
Tympanosclerosis and TM perforation 0 0 4 (8%) 5 (15%) 
Tympanosclerosis and TM retraction 2 (8%) 2 (5%) 6 (12%) 6 (18%) 
TM retraction 2 (8%) 3 (7%) 7 (14%) 5 (15%) 
Cholesteatoma 0 0 1 (2%) 0 
Total 24 41 49 32 
Chronic ear complications  
And History of OME 9 5 39 27 
Normal TM  
And History of OME 7 17 10 5 
 
 
 
Table IV. Incidence of normal tympanic membrane (TM) and chronic middle ear disease 
related to type of cleft at 15 years of age. OME = Otitis Media with Effusion.  
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Figures 
 
 
 
 
Figure 1. Difference between the proportion (%) of children with abnormal hearing (AH) and 
the proportion (%) of children with normal hearing (NH), with or without ventilation tube 
(VT) for the CP (left panel) and CLP groups at different ages. Results from the chi-square 
test with statistical significance are denoted as P < 0.05.* 
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Figure 2. Percentage of children with normal (NH) and abnormal hearing (AH) related to 
ventilation tube (VT) insertion across ages. Children from the cleft palate group (CP) are 
presented in a, children born with cleft lip palate (CLP) are shown in b. Results from the chi-
square test with statistical significance are denoted as P < 0.05.* 
 
 
